Your browser doesn't support javascript.
loading
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
Kim, Joseph M; Bhatt, Deepak L; Dagogo-Jack, Samuel; Cherney, David Z I; Cosentino, Francesco; McGuire, Darren K; Pratley, Richard E; Liu, Chih-Chin; Cater, Nilo B; Frederich, Robert; Mancuso, James P; Cannon, Christopher P.
Affiliation
  • Kim JM; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Bhatt DL; Mount Sinai Heart, Icahn School of Medicine at Mount Sinai Health System, New York, New York, USA.
  • Dagogo-Jack S; University of Tennessee Health Science Center, Memphis, Tennessee, USA.
  • Cherney DZI; University of Toronto, Toronto, Ontario, Canada.
  • Cosentino F; Unit of Cardiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.
  • McGuire DK; University of Texas Southwestern Medical Center, and Parkland Health and Hospital System, Dallas, Texas, USA.
  • Pratley RE; AdventHealth Translational Research Institute, Orlando, Florida, USA.
  • Liu CC; Merck & Co., Inc, Rahway, New Jersey, USA.
  • Cater NB; Pfizer Inc, New York, New York, USA.
  • Frederich R; Pfizer Inc, Groton, Connecticut, USA.
  • Mancuso JP; Pfizer Inc, Groton, Connecticut, USA.
  • Cannon CP; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Diabetes Obes Metab ; 25(5): 1398-1402, 2023 05.
Article in En | MEDLINE | ID: mdl-36594154
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hypertriglyceridemia / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Atherosclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cardiovascular Diseases / Hypertriglyceridemia / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Diabetes Mellitus, Type 2 / Atherosclerosis Type of study: Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: Diabetes Obes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2023 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido